Search Results - "Cani, Eris"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Risk Factors and Clinical Outcomes of Candidemia Associated With Severe COVID-19 by Dixit, Deepali, Jen, Polly, Maxwell, Tyler D., Smoke, Steven, McCracken, James Andrew, Cardinale-King, Maria, Haribhakti, Aditi, Patel, Purvi, Cani, Eris, Choi, Seohyun (Claudia), Jagpal, Sugeet, Varughese, Tilly, Tatem, Luis L., Bhowmick, Tanaya

    Published in Critical care explorations (13-09-2022)
    “…COVID-19 can cause serious illness requiring multimodal treatment and is associated with secondary infections. Studies have suggested an increased risk of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Carbapenem‐resistant Klebsiella pneumoniae vertebral osteomyelitis in a renal transplant recipient treated with ceftazidime‐avibactam by Cani, Eris, Moussavi, Farzad, Ocheretyaner, Eric, Sharma, Roopali, Brown, Clinton, Eilertson, Brandon

    Published in Transplant infectious disease (01-04-2018)
    “…Ceftazidime‐avibactam (CAZ‐AVI) is a novel cephalosporin beta lactamase inhibitor combination that has shown activity against carbapenem‐resistant…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Carbapenem‐resistant K lebsiella pneumoniae vertebral osteomyelitis in a renal transplant recipient treated with ceftazidime‐avibactam by Cani, Eris, Moussavi, Farzad, Ocheretyaner, Eric, Sharma, Roopali, Brown, Clinton, Eilertson, Brandon

    Published in Transplant infectious disease (01-04-2018)
    “…Ceftazidime‐avibactam ( CAZ ‐ AVI ) is a novel cephalosporin beta lactamase inhibitor combination that has shown activity against carbapenem‐resistant…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14